Cellebrite DI (CLBT) Fundamental Analysis: Revenue, Earnings & Valuation

9.55 / 10

Outperform

Fundamentally CLBT is rated Outperform with a 9.55 score. Key strengths include a 16.2% diluted ROE, strong net‑income‑to‑revenue ratio and solid asset returns; weaknesses are low inventory turnover and modest profit‑to‑market value. Overall the fundamentals are deemed outstanding.

Analysis Checks(5/10)

Revenue-MV

Value-1.34

Score3/3

Weight19.32%

1M Return3.91%

Profit-MV

Value-0.19

Score1/3

Weight-15.17%

1M Return-2.90%

Net income-Revenue

Value0.10

Score3/3

Weight103.33%

1M Return12.12%

PB-ROE

Value3.53

Score1/3

Weight-22.56%

1M Return-4.76%

Rate of return on total assets (%)

Value8.16

Score3/3

Weight21.88%

1M Return3.17%

Annualized return on total assets (%)

Value8.16

Score3/3

Weight21.88%

1M Return3.17%

ROE (diluted) (%)

Value16.17

Score3/3

Weight25.07%

1M Return3.72%

Asset-MV

Value-0.55

Score0/3

Weight-27.52%

1M Return-8.51%

Inventory turnover days

Value39.61

Score1/3

Weight-0.26%

1M Return-0.05%

Cash-MV

Value-0.28

Score1/3

Weight-25.98%

1M Return-5.15%

Is CLBT fundamentally strong?

CLBT scores 9.55/10 on fundamentals and holds a Discounted valuation at present. Backed by its 19.10% ROE, 16.47% net margin, 44.58 P/E ratio, 7.21 P/B ratio, and 123.70% earnings growth, these metrics solidify its Outperform investment rating.